The status and role of ErbB receptors in human cancer. (Q37086390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

The status and role of ErbB receptors in human cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Radek Trojanec

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Marián Hajdúch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

I Uberall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

J Berkovcová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

1 reference

5 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

79-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Status of HER-2 in male and female breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Role of exon-16-deleted HER2 in breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Cancer biomarkers: knowing the present and predicting the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Enhanced TGFalpha-EGFR expression and P53 gene alterations contributes to gastric tumors aggressiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

ErbB kinases and NDF signaling in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

c-erbB-2 in breast cancer: development of a clinically useful marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

ErbB and HB-EGF signaling in heart development and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

ErbB2 is required for ductal morphogenesis of the mammary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Receptor signaling: when dimerization is not enough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Epidermal growth factor receptor biology in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

EGF mutant receptor vIII as a molecular target in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

ERBB2 kinase domain mutation in a gastric cancer metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Signal transduction and oncogenesis by ErbB/HER receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Activation of epidermal growth factor receptor kinase in gastric carcinoma: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Prognostic and predictive value of HER2/neu oncogene in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The HER receptor family: a rich target for therapeutic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Chronic hepatitis B virus infection in Asian countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Expression of c-erbB3 protein in primary breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

EGFR and cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Mutations and amplification of oncogenes in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The ErbB signaling network: receptor heterodimerization in development and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Estimates of the worldwide mortality from 25 cancers in 1990.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

c-erbB3 protein expression in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

HER2 protein expression and gene amplification in androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Biological significance of c-erbB family oncogenes in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The HER-2/neu oncogene in tumors of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Epidermal growth factor-related peptides and their receptors in human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Cell signaling by receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: correlation with androgen independence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Lung cancer: intragenic ERBB2 kinase mutations in tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

ErbB receptor negative regulatory mechanisms: implications in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The autocrine loop of TGF-alpha/EGFR and brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

7 January 2021

Focus on gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Gastric adenocarcinoma: pathomorphology and molecular pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

Untangling the ErbB signalling network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.12.002

10.1016/J.YEXMP.2007.12.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279851%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference